Page values for "Brimonidine"
From Pharmacopedia
More actions
"Medicines" values
1 row is stored for this page| Field | Field type | Value |
|---|---|---|
| generic | String | Brimonidine |
| brand | String | Alphagan P (ophthalmic glaucoma), Mirvaso (topical rosacea) |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:Alpha-2_agonists|Alpha-2 adrenergic agonist]] • [[:Category:Glaucoma_medications|Glaucoma medication]] • [[:Category:Ocular_hypotensive_agents|Ocular hypotensive agent]] |
| mechanism | String | |
| uses | String | '"`UNIQ--vote-000010CE-QINU`"', '"`UNIQ--vote-000010CF-QINU`"', '"`UNIQ--vote-000010D0-QINU`"' |
| starting_dose | String | Ophthalmic 1 drop in affected eye(s) TID; topical Mirvaso 0.33% gel applied to face daily |
| preparations | String | 0.1%, 0.15%, 0.2% ophthalmic solutions; 0.33% topical gel; combinations with timolol (Combigan) and brinzolamide (Simbrinza) |
| fda_max | String | TID per eye |
| pill_id | Text | |
| routes | List of String, delimiter: , | Topical ophthalmic • topical skin |
| onset | String | IOP lowering at 1 hour; max at 2-3 hours |
| duration | String | 8-12 hours |
| halflife | String | ~3 hours'"`UNIQ--ref-000010D1-QINU`"' |
| bioavailability | String | Topical; clinically meaningful systemic absorption can produce systemic α2 effects (somnolence, hypotension), especially in children'"`UNIQ--ref-000010D2-QINU`"' |
| pregnancy | String | Limited data.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> |
| legal | String | [[USLegal:Prescription only|Rx-only]] in US |